Vés al contingut

A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat/MK-1242 in Adults With Chronic Heart Failure With Reduced Ejection Fraction

Obert
  • Codi protocol: MK-1242-035
  • Codi EudraCT: 2020-005941-18
  • Servei: Cardiologia
  • Investigador/a principal:  Méndez Fernández, Anna Belén
  • Malaltia: Malalties del sistema circulatori
  • Fase: Fase III
  • Estat reclutament: Reclutant voluntaris